Ciclosporin Capsules
Intended to relieve autoimmune cell proliferation to support chronic organ viability and target inflammatory responses.
- Category
- Autoimmune Support
- Active ingredient
- Ciclosporin
- Route
- Oral use
- Form
- Capsule
- Strengths
- 50mg · 100mg
The exact manufacturer offered is confirmed by the fulfilment partner before supply.
Prescription and consultation requirements for Ciclosporin Capsules vary by destination and are determined by the fulfilment partner.
Ciclosporin Capsules details
- Alternative names
- neoral
- Therapeutic class
- Calcineurin Inhibitor
- Pharmacological class
- Immunosuppressant
- Contraindications
- severe renal impairment; uncontrolled hypertension; malignancies
- Minor side effects
- nausea; headache; tremor
- Moderate side effects
- renal dysfunction; hypertension; hirsutism
- Dosage forms
- Capsule
- Administration route
- Oral use
- Supply category
- Prescription-only medicine (POM)
- Onset Time
- 2–4 weeks
- Duration
- 12–24 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- Ketoconazole; Rifampin; Grapefruit
- Age restrictions
- Approved for paediatric and adult patients.
Serious side effects
severe nephrotoxicity, requires immediate medical attention; severe systemic infections, requires immediate medical attention
Patient summary
intended to relieve autoimmune cell proliferation to support chronic organ viability and target inflammatory responses.
Mechanism of action
Inhibits the activation of calcineurin, suppressing interleukin-2 transcription to prevent T-lymphocyte cell division.
Pregnancy and breastfeeding
TGA Category C: Risk of low birth weight. Avoid unless essential. Breastfeeding: Contraindicated.
What you will receive
Ciclosporin Capsules is a generic medicine sold under the name of its active ingredient, Ciclosporin, rather than under a brand.
- The fulfilment partner confirms the offered manufacturer and product before supply.
- Check the active ingredient, strength, form and pack shown at checkout before confirming an order.